Moaz Elshair

Moaz Elshair

Auto-generated profile, based on publicly available information

Moaz Elshair

Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2021 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
NONozomi Okuno
Nozomi Okuno
KHKazuo WINDOW Hara Hara
Kazuo WINDOW Hara Hara
NMNobumasa Mizuno
Nobumasa Mizuno
SHShin Haba
Shin Haba
TKTakamichi Kuwahara
Takamichi Kuwahara
MEMoaz Elshair
Moaz Elshair
Background/Aims: The Japan Gastroenterological Endoscopy Society (JGES) has published guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. These guidelines classify endoscopic ultrasound-guided biliary drainage (EUS-BD) as a high-risk procedure. Nevertheless, the bleeding risk of EUS-BD in patients undergoing antithrombotic therapy is uncertain. Therefore, this study aimed to assess the bleeding risk in patients undergoing antithrombotic therapy.Methods: This single-center retrospective study included 220 consecutive patients who underwent EUS-BD between January 2013 and December 2018. We managed the withdrawal and continuation of antithrombotic agents according to the JGES guidelines. We compared the bleeding event rates among patients who received and those who did not receive antithrombotic agents.Results: A total of 18 patients (8.1%) received antithrombotic agents and 202 patients (91.8%) did not. Three patients experienced bleeding events, with an overall bleeding event rate of 1.3% (3/220): one patient was in the antithrombotic group (5.5%) and two patients were in the non-antithrombotic group (0.9%) (p=0.10). All cases were moderate. The sole thromboembolic event (0.4%) was a cerebral infarction in a patient in the non-antithrombotic group.Conclusions: The rate of EUS-BD-related bleeding events was low. Even in patients receiving antithrombotic therapy, the bleeding event rates were not significantly different from those in patients not receiving antithrombotic therapy.

30 May 2021 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
MEMoaz Elshair
Moaz Elshair
KHKazuo WINDOW Hara Hara
Kazuo WINDOW Hara Hara
TKTakamichi Kuwahara
Takamichi Kuwahara
NONozomi Okuno
Nozomi Okuno
SHShin Haba
Shin Haba
AMAhmed Massoud
Ahmed Massoud

30 May 2022 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
SHShin Haba
Shin Haba
KHKazuo WINDOW Hara Hara
Kazuo WINDOW Hara Hara
NMNobumasa Mizuno
Nobumasa Mizuno
TKTakamichi Kuwahara
Takamichi Kuwahara
NONozomi Okuno
Nozomi Okuno
MEMoaz Elshair
Moaz Elshair
Endoscopic ultrasound (EUS)-guided hepaticogastrostomy (HGS) is widely performed not only as an alternative to transpapillary biliary drainage, but also as primary drainage for malignant biliary obstruction. For anatomical reasons, this technique carries an unavoidable risk of mispuncturing intrahepatic vessels. We report a technique for troubleshooting EUS-guided portal vein coiling to prevent bleeding from the intrahepatic portal vein after mispuncture during interventional EUS. EUS-HGS was planned for a 59-year-old male patient with unresectable pancreatic cancer. The dilated bile duct (lumen diameter, 2.8 mm) was punctured with a 19-gauge needle, and a guidewire was inserted. After bougie dilation, the guidewire was found to be inside the intrahepatic portal vein. Embolizing coils were placed to prevent bleeding. Embolization coils were successfully inserted under stabilization of the catheter using a double-lumen cannula with a guidewire. Following these procedures, the patient was asymptomatic. Computed tomography performed the next day revealed no complications.

30 May 2023 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
ABAsmaa Bakr
Asmaa Bakr
KHKazuo WINDOW Hara Hara
Kazuo WINDOW Hara Hara
MEMoaz Elshair
Moaz Elshair
SHShin Haba
Shin Haba
TKTakamichi Kuwahara
Takamichi Kuwahara
HOHanaa Omar
Hanaa Omar
Background/Aims: Endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA) using oblique-view EUS in patients with a surgically altered anatomy (SAA) of the upper gastrointestinal tract is limited because of difficult scope insertion due to the disturbed anatomy. This study aimed to investigate the efficiency of forward-view (FV)-EUS in performing FNA in patients with a SAA.Methods: We retrospectively investigated 32 patients with a SAA of the upper gastrointestinal tract who visited Aichi Cancer Center Hospital in Nagoya, Japan, between January 2014 and December 2020. We performed-upper gastrointestinal EUS-FNA using FV-EUS combined with fluoroscopic imaging to confirm tumor recurrence or to make a decision before chemotherapy or after a failure of diagnosis by radiology.Results: We successfully performed EUS-FNA in all studied patients (100% technical success), with the specificity, sensitivity, and accuracy of 100%, 87.5%, and 87.8%, respectively, with no complications.Conclusions: EUS-FNA using FV-EUS combined with fluoroscopic imaging is an effective and safe technique for tissue acquisition in patients with a SAA.

25 October 2021 in Endoscopy
Verified
Journal Article
Closed access
PDF file
MEMoaz Elshair
Moaz Elshair
KHKazuo WINDOW Hara Hara
Kazuo WINDOW Hara Hara
SHShin Haba
Shin Haba
TKTakamichi Kuwahara
Takamichi Kuwahara
NONozomi Okuno
Nozomi Okuno
MAMohamed Z. Abu-Amer
Mohamed Z. Abu-Amer
Gastric cancer is the second leading cause of cancer mortality all over the world. Although early detection has increased the curative resection, many cases still present in an advanced stage with gastric outlet obstruction and lymph node metastasis [1] [2]. Here, we report a novel technique for palliative management of pyloric obstruction and obstructive jaundice in the same session using a forward-viewing echoendoscope. A 71-year-old patient with advanced gastric cancer presented with pyloric obstruction and hilar obstructive jaundice ( [Fig.1]). We decided on palliative management including duodenal stenting and an endoscopic ultrasound (EUS)-guided hepaticogastrostomy using a forward-viewing echoendoscope. First, we marked the esophagogastric junction with an endoclip to avoid transesophageal puncture. We advanced the forward-viewing echoendoscope down to the gastric antrum. Under fluoroscopic guidance, the stricture site was determined and then cannulated with a 0.25-inch guidewire within the catheter ([Fig. 1]). A 2.2-cm × 12-cm uncovered duodenal stent (HANAROSTENT; Olympus, Tokyo, Japan) was advanced over the guidewire traversing the stricture site, both ends of the stent were carefully monitored, and then the stent was successfully deployed ([Fig. 2]). Second, we visualized the liver and determined the bile duct of segment 2 (B2) with the same endoscope. We punctured B2 using a 22-gauge needle (Expect Slimline (SL); Boston Scientific, Marlborough, Massachusetts) with a preloaded 0.018-inch guidewire ([Fig. 3]). After bile duct confirmation by contrast medium, we dilated the track by using a 7-Fr mechanical dilator (ES dilator; ZEON Medical, Tokyo, Japan). We successfully deployed the hepaticogastrostomy stent (5.9-Fr delivery system, HANAROSTENT Benefit, 6 mm × 10 cm, fully covered; Boston Scientific) ([Fig. 4]). Here, we recommend a forward-viewing echoendoscope for both duodenal stenting and EUS-guided hepaticogastrostomy. With a wide working channel and forward-view orientation, this endoscope allows the output of the duodenal stent easily over the guidewire. Moreover, it enabled us to perform the hepaticogastrostomy at the same time. In comparison to the curved echoendoscope, the forward-viewing echoendoscope makes transgastric B2-puncture easier because of the forward-view orientation [3]. We successfully deployed the duodenal stent and performed the hepaticogastrostomy easily using only a forward-viewing echoendoscope ([Video 1]). Video 1 How to perform duodenal stenting and endoscopic ultrasound-guided hepaticogastrostomy using only a forward-viewing echoendoscope. Endoscopy_UCTN_Code_CPL_1AH_2AD Publication Date: 25 October 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

30 July 2024 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
MEMoaz Elshair
Moaz Elshair
KHKazuo WINDOW Hara Hara
Kazuo WINDOW Hara Hara
NONozomi Okuno
Nozomi Okuno
SHShin Haba
Shin Haba
TKTakamichi Kuwahara
Takamichi Kuwahara
MAMohamed Z. Abu-Amer
Mohamed Z. Abu-Amer
Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) through ducts B2 or B3 is effective in most patients with biliary obstruction, because B2 and B3 commonly join together. However, in some patients, B2 and B3 do not join each other due to invasive hilar tumors; therefore, single-route drainage is insufficient. Here, we investigated the feasibility and efficacy of EUS-HGS through both B2 and B3 simultaneously in seven patients. We decided to perform EUS-HGS through both B2 and B3 to achieve adequate biliary drainage because these two ducts were separate from each other. Here, we report a 100% technical and overall clinical success rate. Early adverse effects were closely monitored. Minimal bleeding was reported in one patient (1/7) and mild peritonitis in one patient (1/7). None of the patients experienced stent dysfunction, fever, or bile leakage after the procedure. EUS-HGS through both B2 and B3 simultaneously is safe, feasible, and effective for biliary drainage in patients with separated ducts.